Explore
Validate
LearnMA1-82895
antibody from Invitrogen Antibodies
Targeting: CGA
FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-82895 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Follicle Stimulating Hormone alpha Monoclonal Antibody (F1 (BGN/F62/01))
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Mouse anti Human FSH alpha antibody, clone F1 (BGN/F62/01) detects the alpha subunit of Follicle-stimulating hormone (FSH alpha).
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- F1 (BGN/F62/01)
- Vial size
- 1 mg
- Concentration
- 1 mg/mL
- Storage
- 4°C or -20°C if preferred
Submitted references Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.
Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis.
Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.
NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.
Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection.
Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy.
Peculis R, Mandrika I, Petrovska R, Dortane R, Megnis K, Nazarovs J, Balcere I, Stukens J, Konrade I, Pirags V, Klovins J, Rovite V
Frontiers in endocrinology 2020;11:313
Frontiers in endocrinology 2020;11:313
Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis.
Idali F, Wahlström J, Dahlberg B, Khademi M, Olsson T, Eklund A, Grunewald J
Respiratory research 2009 May 29;10(1):42
Respiratory research 2009 May 29;10(1):42
Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.
Thomas S, Xue SA, Cesco-Gaspere M, San José E, Hart DP, Wong V, Debets R, Alarcon B, Morris E, Stauss HJ
Journal of immunology (Baltimore, Md. : 1950) 2007 Nov 1;179(9):5803-10
Journal of immunology (Baltimore, Md. : 1950) 2007 Nov 1;179(9):5803-10
NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
Maccalli C, Nonaka D, Piris A, Pende D, Rivoltini L, Castelli C, Parmiani G
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Dec 15;13(24):7459-68
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Dec 15;13(24):7459-68
Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.
Vonderheid EC, Boselli CM, Conroy M, Casaus L, Espinoza LC, Venkataramani P, Bigler RD, Hou JS
The Journal of investigative dermatology 2005 Mar;124(3):651-61
The Journal of investigative dermatology 2005 Mar;124(3):651-61
Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection.
Xu B, Sakkas LI, Goldman BI, Jeevanandam V, Gaughan J, Oleszak EL, Platsoucas CD
Cellular immunology 2003 Oct;225(2):75-90
Cellular immunology 2003 Oct;225(2):75-90
Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Sano S, Matsui Y, Itami S, Yoshikawa K
Clinical and experimental immunology 1998 Aug;113(2):190-7
Clinical and experimental immunology 1998 Aug;113(2):190-7
Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Sano S, Matsui Y, Itami S, Yoshikawa K
Clinical and experimental immunology 1998 Aug;113(2):190-7
Clinical and experimental immunology 1998 Aug;113(2):190-7
Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J
Cancer research 1997 Oct 15;57(20):4570-7
Cancer research 1997 Oct 15;57(20):4570-7
Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy.
Janson CH, Tehrani MJ, Mellstedt H, Wigzell H
Cancer immunology, immunotherapy : CII 1989;28(3):225-32
Cancer immunology, immunotherapy : CII 1989;28(3):225-32
No comments: Submit comment
No validations: Submit validation data